Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
May
10
2013
A First for Fair, Reasonable and Non-Discriminatory (FRAND): Federal Court in Microsoft v. Motorola Sets FRAND Royalty Rates for Standard Essential Patents McDermott Will & Emery
Aug
30
2013
A Generic Disclosure Does Not Support Claims to Individual Species Re: Protein Variants and Litigation McDermott Will & Emery
Nov
1
2018
A Glimpse of Things to Come: OSHA’s Soon to Be Updated Hazard Communication Standard Bergeson & Campbell, P.C.
Apr
23
2024
A Greener World Asks FSIS to Seek Input on “Free Range” and “Pasture-Raised” Claims Keller and Heckman LLP
Oct
31
2017
A Growing Trend In Favor of Medical Marijuana Users in the Employment Context Epstein Becker & Green, P.C.
Feb
22
2024
A Guide for FDA Whistleblowers Oberheiden P.C.
Feb
1
2018
A Guide to New Jersey’s New Limits on Pharmaceutical Industry Payments to Prescribers Mintz
Jul
23
2020
A Legen-dairy Victory: Ben & Jerry’s Wins “Happy Cows” False Advertising Lawsuit Proskauer Rose LLP
Sep
20
2011
A Liquid Layer Solution for the Grid U.S. Department of Energy
Nov
13
2023
A Look at FDA’s Proposed Changes to Labeling for Biosimilars and Interchangeable Biosimilars Foley & Lardner LLP
Aug
2
2019
A Look at the Food Handler Antiseptic OTC Rulemaking Keller and Heckman LLP
Mar
29
2011
A MATRIXX Revolution, Part II: Supreme Court affirms Ninth Circuit's holding that Life Science Companies Cannot Rely On a Statistical Significance Standard When Deciding Whether Adverse Event Reports are Material for the Purpose of Securities Disclosures Sheppard, Mullin, Richter & Hampton LLP
Jan
17
2020
A Mixed Bag on New Rules – Juggling Copyright Preclusion and Patent Infringement McDermott Will & Emery
May
9
2020
A Move to Mandatory: Japan Finalizes its Positive List for “Synthetic Resins” Keller and Heckman LLP
May
22
2020
A Move to Mandatory: Japan Finalizes Positive List for "Synthetic Resins" in Food-Contact Articles Keller and Heckman LLP
Mar
22
2024
A Moving Target: Recent New Jersey Case Shows Changing Laws Complicate Cannabis Business Norris McLaughlin P.A.
Sep
17
2020
A NanoBCA Retrospective — A Conversation with Vincent Caprio [PODCAST] Bergeson & Campbell, P.C.
Jul
15
2021
A New Commodity in a Traditional Box: Hemp's Commodity Status Demands Appropriate Attention Ward and Smith, P.A.
May
6
2024
A New Day for “Natural” Claims? Keller and Heckman LLP
Jan
25
2024
A New Era For New Jersey’s Liquor Law: Comprehensive Reforms Enacted Norris McLaughlin P.A.
Dec
18
2012
A New Fate for Holiday Leftovers? Mintz
May
13
2022
A New(ish) Chemical Excise Tax Effective July 2022 Proskauer Rose LLP
Jun
14
2018
A Pom Wonderful World: F&B Makers’ New Adversary Bilzin Sumberg
Apr
12
2019
A Practical Guide for Multistate Employers on Managing the Growing Patchwork of Marijuana Laws Bracewell LLP
Mar
14
2016
A Practical Understanding of the Polymer Exemption Keller and Heckman LLP
Mar
15
2017
A Prior Art Reference that Merely Suggests the Claimed Subject Matter Does Not Anticipate the Claims Hunton Andrews Kurth
Apr
12
2018
A pro-active approach to doping – raising the bar at the Commonwealth Games Squire Patton Boggs (US) LLP
Mar
21
2024
A Psychedelic Use Case for AI Nelson Mullins
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins